At a glance
- Originator Pharmacia Corporation
- Class Anti-inflammatories; Antirheumatics; Bisphosphonates
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Rheumatic disorders
Most Recent Events
- 09 Mar 1999 Profile reviewed
- 30 Jan 1996 Preclinical development for Inflammation in USA (Unknown route)
- 30 Jan 1996 Preclinical development for Rheumatic disorders in USA (Unknown route)